日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response.

tRNA苏氨酰化作用的破坏会触发RIG-I介导的抗肿瘤免疫反应。

Dziagwa Cléa, Seca Christian, Capron Coralie, Maurizy Chloe, An Ning, Heusdens Denis, Budden Timothy, Martin-Morales Lorena, Susaeta Ruiz Miguel, Renaude Elodie, El-Hachem Najla, Vanleyssem Raphael, Leclercq Marine, Blomme Arnaud, Chariot Alain, Utikal Jochen, Viros Amaya, Rapino Francesca, Delaunay Sylvain, Close Pierre

Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

根据 BRCA1/2 突变类型和部位评估新诊断卵巢癌患者接受 PARP 抑制剂维持治疗的获益:一项多中心真实世界研究

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Not all BRCA mutations are equal: functional context and mutation type as co-determinants of PARP inhibitor response

关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处:一项多中心真实世界研究”的来信回复:并非所有BRCA突变都相同:功能背景和突变类型是PARP抑制剂疗效的共同决定因素

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Response to letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

回复关于“根据BRCA1/2突变类型和部位评估PARP抑制剂维持治疗对新诊断卵巢癌患者的益处:一项多中心真实世界研究”的来信

Marchetti, C; Fagotti, A; Fruscio, R; Cassani, C; Incorvaia, L; Perri, M T; Sassu, C M; Camnasio, C A; Giudice, E; Minucci, A; Seca, M; Arbustini, E; Vertechy, L; De Bonis, M; Boccia, S M; Giannarelli, D; Salutari, V; Distefano, M; Ferrandina, M G; Nero, C; Musacchio, L; Russo, A; Scambia, G; Lorusso, D

Antiaging Potential of Lipophilic Extracts of Caulerpa prolifera

海葡萄脂提取物的抗衰老潜力

Rosa, Gonçalo P; Barreto, Maria Carmo; Seca, Ana M L; Pinto, Diana C G A

Treatment of infertility and risk of breast cancer among women with a BRCA pathogenic variant: a matched case-control study

BRCA致病变异女性不孕症治疗与乳腺癌风险:一项匹配病例对照研究

Seca, Marta; Gronwald, Jacek; Huzarski, Tomasz; Glass, Karen; Aeilts, Amber; Kim, Raymond H; Karlan, Beth; Singer, Christian F; Eisen, Andrea; Tung, Nadine; Olopade, Olufunmilayo; Bordeleau, Louise; Moller, Pal; Foulkes, William D; Neuhausen, Susan L; Couch, Fergus; Pal, Tuya; Fruscio, Robert; Cybulski, Cezary; Lubinski, Jan; Kim, Shana; Sun, Ping; Narod, Steven A; Kotsopoulos, Joanne

Exploring the Therapeutic Potential of Artemisia and Salvia Genera in Cancer, Diabetes, and Cardiovascular Diseases: A Short Review of Clinical Evidence

探索蒿属和鼠尾草属植物在癌症、糖尿病和心血管疾病中的治疗潜力:临床证据简述

Tavares, Wilson R; Seca, Ana M L; Barreto, Maria Carmo

A woman with a pleural mesothelioma and an inherited ATM mutation-a case report

一名患有胸膜间皮瘤且携带遗传性ATM基因突变的女性——病例报告

Seca, Marta; Cho, B C John; Tryon, Angelina; Narod, Steven A

New Phytol Derivatives with Increased Cosmeceutical Potential

具有更高药妆潜力的新型植醇衍生物

Rosa, Gonçalo P; Seca, Ana M L; Pinto, Diana C G A; Barreto, M Carmo

Understanding climate literacy research using scientometrics analysis

运用科学计量学分析理解气候素养研究

Rahmawaty; Ismail, Mohd Hasmadi; Rauf, Abdul; Abdullah, Muhammad Fuad; Mohd Noor, Mohd Iqbal; Ayu Amir Mustafa, Amira Mas; Gandaseca, Seca; Karuniasa, Mahawan; Kim, Yekyoum; Suratman, Mohd Nazip; Salleh, Siti Aekbal; Tedong, Peter Aning